Jump to main content Jump to footer
  • DE
Skip navigation
Jump to navigation start
  • DE
HomeApplication AreaPharma
WIDE RANGE OF INTERMEDIATE PRODUCTS FOR THE PHARMACEUTICAL INDUSTRY - BACK TO EUROPE

Pharma

We offer more than just a product, we provide future-oriented solutions with the following intermediate products.

  • Bioselect® (high-purity guanidine salts) for biotechnological, diagnostic and pharmaceutical applications.
  • Cyanamide as an anti-worm agent for human and veterinary medicine.
  • Dicyandiamide as a synthesis building block for active pharmaceutical ingredients (API's), e.g. for the production of metformin (medication against type II diabetes).
  • NITRALZ® (nitriles) for the API production of various medicines for the treatment of e.g. hypertension, heart disease, HIV and cancer.
  • NIGU® (Nitroguanidine) as an intermediate in the synthesis of pharmaceuticals and veterinary products
  • Thiourea as a raw material for the production of various human medicines, e.g. for the treatment of Parkinson's disease.

Innovation, sustainability, health & safety play a fundamental role.

We have more than 60 years of experience in the development and manufacture of advanced, high-quality specialty and intermediate products for pharmaceutical applications.

In cooperation with you, we develop tailor-made solutions, such as customized buffer solutions based on guanidine thiocyanate and guanidine hydrochloride. Thanks to our many years of experience and our wide range of technologies, we can offer you a comprehensive service.

Due to our deep market and customer understanding and our stable supply chain, we are able to offer reliable and consistently high quality "Made in Germany" products.

Skip slider
Bioselect®
Mitarbeiter im Labor
Toll manufacturing
Weiße Tabletten in orangener Dose
Cyanamide
Dicyandiamide
Nitralz®
Thiourea
Jump to slider start

Pharma Flyer

PDF

Pharma Flyer

1 MB
5 Puzzelteile

Act now.

Act together.

 

The Alzchem Group forms a unique production network. Such an interconnected system conserves resources, saves energy, reduces emissions, transport costs and uses the synergies of an integrated infrastructure.

News and Stories

Andreas Niedermaier
Alzchem, Corporate News
Contract extension CEO Andreas Niedermaier until 2026

Trostberg, 12 Mai 2023 – The Supervisory Board of Alzchem Group AG has extended early the service contract of Chief Executive Officer Andreas Niedermaier, which runs until 31 December 2023, by 3 years until 2026.

Alzchem, Corporate News
Annual General Meeting 2023 of Alzchem Group AG

The shareholders of Alzchem Group AG, a vertically integrated specialty chemicals supplier with a leading market position in selected niche markets, approved all items on the agenda with a large majority at today’s virtual Annual General Meeting.

YouTube is deactivated

We need your consent to use YouTube videos. For more information, see our Privacy Policy.

Vimeo is deactivated

We need your consent to use Vimeo videos. For more information, see our Privacy Policy.

Google Maps is deactivated

We need your consent to use Google Maps. For more information, see our Privacy Policy.